DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease

Stan Heptinstall Professor of Thrombosis and Haemostasis Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UKCorrespondence[email protected]

David Iyu Espinosa Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK

Panagiotis Manolopoulos Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK

Jackie R. Glenn Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK

Ann E. White Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK

Andrew Johnson Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK

Natalia Dovlatova Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK

Sue C. Fox Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK

Jane A. May Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK

David Hermann deCODE genetics Inc., Brighton, MI, USA

Olafur Magnusson deCODE genetics Inc., Reykjavik, Iceland

Kari Stefansson deCODE genetics Inc., Reykjavik, Iceland

Dan Hartman deCODE genetics Inc., Brighton, MI, USA

Mark Gurney deCODE genetics Inc., Woodridge, IL, USA

Your download is now in progress and you may close this window